Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2018 ^a indicates ≥1.50 SD (17.9) from the mean (32.9... by Luke R. Cavanah (19022435)

Large state-wide variation (11.1-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2015 ^a indicates ≥1.50 SD (20.2) from the mean (36.... by Luke R. Cavanah (19022435)

Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2017 ^a indicates ≥1.50 SD (18.0) from the mean (33.1... by Luke R. Cavanah (19022435)

Large state-wide variation (8.5-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2019 ^a indicates ≥1.50 SD (16.8) from the mean (31.0... by Luke R. Cavanah (19022435)

Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2020 ^a indicates ≥1.50 SD (16.0) from the mean (29.9... by Luke R. Cavanah (19022435)

Large state-wide variation (10.2-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2016 ^a indicates ≥1.50 SD (19.2) from the mean (34.... by Luke R. Cavanah (19022435)

Medicare clozapine data analysis. by Luke R. Cavanah (19022435)

“…For all years, there was pronounced geographic heterogeneity (average: nine-fold) in population-corrected clozapine use. Massachusetts (2015−20: 95.4, 82.7, 76.8, 72.2, 71.2, 63.7 prescriptions per thousand enrollees) and South Dakota (2015−20: 78.0, 77.4, 78.4, 75.6, 72.0, 71.6) were the only states that prescribed significantly more than average, and none prescribed significantly less. …”

Early IL-33 administration increases trTregs and ILC2 numbers but does not enhance parasite-specific CD8+ T cells at 10 days post infection. by Santiago Boccardo (5927954)

Early IL-33 administration expands trTregs and improves disease outcome in infected mice. by Santiago Boccardo (5927954)

Flowchart of Methodology. by Kamal Hossain (331680)

“…The case fatality rate also demonstrated a steadily rise, reaching 0.5% in 2023 with 321,179 cases (a five-fold increase compare to 2022). Interestingly, the proportion of cases in Dhaka city decreased from 51% in 2019 to 34% in 2023. …”

Patients outcome. by Loïc Duron (6433634)

“…Reliance on temporal-artery biopsy fell (17% vs 91%; p < 0.01), owing to a four-fold rise in diagnostic MRI use. Mean total medical costs decreased by €814 per patient (€3672 ± 2861 vs €4486 ± 3193), although this difference did not reach statistical significance (p = 0.23).…”

Trial design. by Llum Páez (22553360)

“…Vaccination against canine leishmaniasis intends to decrease the parasite burden and the risk of clinical disease. …”

Schedule of the trial. by Llum Páez (22553360)

“…Vaccination against canine leishmaniasis intends to decrease the parasite burden and the risk of clinical disease. …”

Clinical symptoms scoring system. by Llum Páez (22553360)

“…Vaccination against canine leishmaniasis intends to decrease the parasite burden and the risk of clinical disease. …”

Marketed vaccines against canine leishmaniasis. by Llum Páez (22553360)

“…Vaccination against canine leishmaniasis intends to decrease the parasite burden and the risk of clinical disease. …”

Presentation 1_Global patterns of change in the burden of malnutrition in older adults from 1990 to 2021 and the forecast for the next 25 years.pdf by Le Li (356426)

“…</p>Results<p>In 2021, over 97.60 million cases of malnutrition among the elderly were reported globally, a 1.2-fold increase from 44.36 million cases in 1990. The global prevalence rate of malnutrition has decreased with an EAPC of −0.32%. …”

Data Sheet 8_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf by Erman Wu (19021269)

“…In contrast, the APMP-related burden increased among adults aged 20 years and older. …”

Data Sheet 5_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf by Erman Wu (19021269)

“…In contrast, the APMP-related burden increased among adults aged 20 years and older. …”

Data Sheet 1_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf by Erman Wu (19021269)

“…In contrast, the APMP-related burden increased among adults aged 20 years and older. …”

Data Sheet 7_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf by Erman Wu (19021269)

“…In contrast, the APMP-related burden increased among adults aged 20 years and older. …”